Abstract
Background There is an urgent need to assess the role of schools in the spread of SARS-CoV-2 in Canada to inform public health measures. We describe the epidemiology of SARS-CoV-2 infection in students and staff in the Vancouver Coastal Health (VCH) region in the first three months of the 2020/2021 academic year, and examine the extent of transmission in schools.
Methods This descriptive epidemiologic study using contact tracing data included all SARS-CoV-2 cases reported to VCH between September 10 and December 18, 2020 who worked in or attended K-12 schools in-person. Case and cluster characteristics were described.
Results There were 699 school staff and student cases during the study period, for an incidence of 55 cases per 10,000 population, compared to 73 per 10,000 population in all VCH residents. Among VCH resident staff and student cases, 53% were linked to a household case/cluster, <1.5% were hospitalized and there were no deaths. Out of 699 cases present at school, 26 clusters with school-based transmission resulted in 55 secondary cases. Staff members accounted for 54% of index cases (14/26) while comprising 14% of the school population. Among clusters, 88% had fewer than 4 secondary cases.
Interpretation COVID-19 incidence in the school population was lower than that of the general population. There were no deaths and severe disease was rare. School-based transmissions of SARS-CoV-2 were uncommon and clusters were small. Our results support the growing body of evidence that schools do not play a major role in the spread of SARS-CoV-2.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Neither the study authors nor their institutions received payment or services at any time from any third parties for any aspects of the submitted work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In consultation with UBC Office of Research Ethics, this study did not require institutional research ethics review according to Article 2.5 of the Tri-Council Policy Statement (TCPS2), as it was completed as part of routine public health surveillance and quality assurance/quality improvement.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.